Product Name | MF | CAS | Details |
---|
PDE4-IN-8 | C18H22BNO4 | 2415085-45-7 | Details |
mGluR2 modulator 2 | C20H22FN3 | 1004614-86-1 | Details |
Antiparasitic agent-6 | C19H15N3O3 | 2253996-73-3 | Details |
Tubulin polymerization-IN-27 | C22H20N2O2 | 2462030-32-4 | Details |
Antibacterial agent 121 | C18H22N2O3S | 474099-18-8 | Details |
Xanthine oxidase-IN-5 | C18H16FN3O3 | 2276711-87-4 | Details |
gp120-IN-1 | C15H18N2O4S | 5948-75-4 | Details |
SARS-CoV-2-IN-18 | C20H14N2O3 | 184904-82-3 | Details |
UCSF648 | C15H19ClN2O2S | 2637090-55-0 | Details |
α-Glucosidase-IN-8 | C19H20FN3O2 | 2448345-96-6 | Details |
Adenosine receptor antagonist 3 | C16H14N6S | 2400864-80-2 | Details |
L-I-OddU | C8H9IN2O5 | 207920-87-4 | Details |
PDE4-IN-9 | C15H12N4O3S | 2519450-32-7 | Details |
Neuraminidase-IN-6 | C16H16N4O2S | 2738526-22-0 | Details |
Antitubercular agent-17 | C14H12BrN5O | 2328751-33-1 | Details |
NMDA receptor modulator 4 | C13H9F3N2O3S | 2758256-71-0 | Details |
Factor VII-IN-1 | C15H10BrNO3 | 244206-28-8 | Details |
BChE-IN-14 | C24H29N | 2700896-78-0 | Details |
Anticandidal agent-1 | C19H22O5 | 2548852-85-1 | Details |
SLK/STK10-IN-1 | C17H13ClN2O3 | 264210-49-3 | Details |
HBV-IN-25 | C18H14ClNO4 | 2161364-69-6 | Details |
ZL-Pin01 | C14H17ClN2O3S | 1047464-92-5 | Details |
hCAIX/XII-IN-2 | C19H14N2O4 | 2414629-82-4 | Details |
Antitubercular agent-21 | C15H22N6OS | 2412142-93-7 | Details |
HDAC1/MAO-B-IN-1 | C18H17ClN2O2 | 2759855-37-1 | Details |
PXYC13 | C15H15N5O2S | 1031940-69-8 | Details |
Tubulin polymerization-IN-31 | C18H13ClFN3 | 2421121-79-9 | Details |
CAXII-IN-1 | C13H7Cl2NO3S | 2479918-59-5 | Details |
KCa2 channel modulator 1 | C16H15ClFN5 | 1019106-73-0 | Details |
S07-2001 | C15H17N3O4S | 1197904-57-6 | Details |
Ep vinyl quinidine | C20H24N2O2 | 101143-87-7 | Details |
LDHA/PDKs-IN-2 | C17H20N2O5 | 2490699-44-8 | Details |
IKK-IN-4 | C18H19N5S | 615529-94-7 | Details |
SCH-42354 | C16H23NO3S2 | 144505-58-8 | Details |
NBD-125 | C19H18ClNO2 | 2367641-24-3 | Details |
Myt1-IN-3 | C18H19N5O2 | 2719793-54-9 | Details |
TK4b | C21H22N2O2 | 2232890-81-0 | Details |
RIPK1-IN-15 | C19H19N3O2 | 2755704-34-6 | Details |
Anticancer agent 70 | C13H9Cl2N3O2S | 2521770-35-2 | Details |
LANA-DNA-IN-1 | C19H14N4O2 | 2512847-06-0 | Details |
JMI-105 | C20H23N3O2 | 2227315-30-0 | Details |
As-358 hydrochloride | C18H32ClNO2 | 2374723-26-7 | Details |
Androgen receptor antagonist 4 | C22H18ClN | 354815-43-3 | Details |
HIF-1/2α-IN-2 | C16H11FN4O2S | 862974-22-9 | Details |
ERD03 | C21H25NO3 | 1377897-01-2 | Details |
CBR-3465 | C16H18FN3O2S | 2225883-59-8 | Details |
Tubulin polymerization-IN-37 | C19H20N2O4 | 2011784-92-0 | Details |
Vin-F03 | C22H29N3 | 2180917-11-5 | Details |
BRG1-IN-1 | C20H19FN2O | 2616813-99-9 | Details |
Antitubercular agent-14 | C20H27ClN2 | 2408627-49-4 | Details |
DPP-4-IN-2 | C18H18N6O | 2133900-95-3 | Details |
Xanthine oxidoreductase-IN-1 | C18H20N4O2 | 2396612-00-1 | Details |
BChE-IN-7 | C21H24N2O2 | 2416910-85-3 | Details |
ZINC12409120 | C20H16N4O2 | 1010888-06-8 | Details |
Pirepemat fumarate | C15H17F2NO5 | 2251806-70-7 | Details |
c-ABL-IN-2 | C21H20N4O | 2574593-54-5 | Details |
YXL-13 | C13H15BrN2O4 | 2415981-79-0 | Details |
SSTR4 agonist 3 | C18H24N4OS | 2744188-34-7 | Details |
α-Glucosidase-IN-9 | C19H12N4OS | 735273-33-3 | Details |
Anticancer agent 75 | C22H24N2O | 2414491-13-5 | Details |
VU6010572 | C20H18FNO3 | 2126784-39-0 | Details |
Polvitolimod | C13H14FN5O4 | 2389988-81-0 | Details |
PK9327 | C21H22N2S | 2413987-20-7 | Details |
RXFP3 agonist 1 | C18H18ClN5 | 2752378-24-6 | Details |
COX-1/2-IN-3 | C14H8N2O8 | 2428387-82-8 | Details |
B-Raf IN 7 | C15H16N6O3 | 2477725-07-6 | Details |
Antibacterial agent 111 | C18H12N6S | 2448358-84-5 | Details |
NMDA receptor modulator 5 | C14H11F3N2O3S | 2758256-97-0 | Details |
Antitubercular agent-18 | C14H12BrN5O | 1308272-99-2 | Details |
Antitubercular agent-27 | C14H8BrN3O3 | 2460651-09-4 | Details |
CD73-IN-8 | C17H13ClN4O2 | 2763710-08-1 | Details |
IDO1/TDO-IN-3 | C16H6ClF2N3O2 | 2347579-03-5 | Details |
Dopamine D4 receptor antagonist-1 | C18H19ClN4 | 444724-92-9 | Details |
Caprochlorone | C19H19ClO3 | 13878-10-9 | Details |
MAO-B-IN-11 | C22H32O3 | 192383-78-1 | Details |
S07-2009 | C16H19N3O5 | 1580241-55-9 | Details |
HPK1-IN-24 | C19H14FN5 | 2294966-07-5 | Details |
hMAO-B-IN-3 | C20H15NO4 | 2581113-51-9 | Details |
Antibacterial agent 95 | C19H16ClNO3 | 2413006-48-9 | Details |
PXYC12 | C15H15N5O2S | 1112415-91-4 | Details |
Pim-1 kinase inhibitor 3 | C20H25N3O2 | 2801695-39-4 | Details |
Androgen receptor antagonist 3 | C22H18ClN | 353484-46-5 | Details |
HOE961 | C13H17N5O5 | 152819-48-2 | Details |
Antituberculosis agent-2 | C19H17NO4 | 2411741-01-8 | Details |
HDAC6-IN-11 | C19H16N2O4 | 2409072-27-9 | Details |
RSK-IN-1 | C22H17NO2 | 2761698-77-3 | Details |
MAT2A-IN-4 | C18H16ClN3O | 2439272-57-6 | Details |
S(-)-Bisoprolol | C18H31NO4 | 99103-03-4 | Details |
HG122 | C15H13N5O5 | 1854976-77-4 | Details |
SDR-04 | C19H16N4O2 | 879593-54-1 | Details |
GABAA receptor agent 7 | C18H13ClN4O | 2376841-18-6 | Details |
CD73-IN-11 | C14H10F3N5O2 | 2766566-11-2 | Details |
CD73-IN-10 | C15H13F2N5O2 | 2766565-91-5 | Details |
JMI-346 | C19H20N4O2 | 2091841-46-0 | Details |
SSTR4 agonist 4 | C19H26N4O | 2747928-27-2 | Details |
Aldose reductase-IN-5 | C18H15NO5 | 2480090-03-5 | Details |
TRβ agonist 3 | C20H25NO3 | 2411099-46-0 | Details |
UC-1V150 | C16H17N5O4 | 927822-45-5 | Details |
A1AR antagonist 5 | C17H15ClN4O | 1030509-01-3 | Details |
Hepcidin antagonist-1 | C16H13Cl2N5 | 338965-09-6 | Details |
Product Total: Product Page: | ||||
108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 |